In this Issue
Leading researchers discuss current current techniques and research initiatives in the spectrum of venous disease intervention.
CHIEF MEDICAL EDITOR’S PAGE
By Barry T. Katzen, MD, Chief Medical Editor
An update on the ATTRACT trial.
By Suresh Vedantham, MD
A new paradigm and therapy for multiple sclerosis.
By Salvatore J.A. Sclafani, MD
Commentary by Michael D. Dake, MD,
and Barry T. Katzen, MD
Because bone vascular AVMs are rarely seen in day-to-day practice, clinicians should be aware of the steps for proper diagnosis and the available treatment options to improve patient outcomes.
By Wayne F. Yakes, MD
A clinic with this singular focus may improve the retrieval rates of optional IVC filters.
By Jeet Minocha, MD; Robert K. Ryu, MD; Jennifer Karp, RN; and Robert J. Lewandowski, MD
Explore the ways interventionists can pursue further expertise by expanding their knowledge and techniques.
By Steve Elias, MD, FACS, FACPH
John R. Laird Jr, MD, and Barry T. Katzen, MD, the principal investigators of the recently published RESILIENT trial, discuss the current SFA study landscape and explain that although angioplasty alone may be sufficient for short lesions, these data show that there is a place for stenting in this challenging vessel.
How to use an endovascular approach in the diagnosis and treatment of combined iliac and renal anastomotic stenoses.
By Grace J. Wang, MD, and Matthew H. Levine, MD, PhD
Interventional procedures for removing malfunctioned, fractured, or migrated devices.
By Kenneth R. Thomson, MD, FRANZCR
Dr. Starnes discusses his military physician training and his closure protocol for EVAR patients.